Investigating how brain cells influence nicotine addiction and withdrawal behaviors.
Role of glial expression in nicotine behaviors for genes identified through human GWAS
This study is looking at how certain brain cells called astrocytes might play a part in helping people who are addicted to nicotine and dealing with withdrawal, using animal models to understand how genes related to smoking can affect these cells and potentially lead to better treatments for quitting tobacco.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Colorado NIH-funded |
| Lab location | 1 site (Boulder, UNITED STATES) |
| Project ID | NIH-11119330 on NIH RePORTER |
What this research studies
This research explores the role of astrocytes, a type of brain cell, in nicotine addiction and withdrawal behaviors. By examining genes linked to smoking behaviors identified through large-scale genetic studies, the project aims to uncover how these genes may affect astrocyte function and, in turn, influence nicotine dependence. The study utilizes animal models to assess behavioral responses to nicotine and the effects of abstinence, providing insights that could lead to new treatment strategies for tobacco addiction.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals struggling with nicotine addiction or those who have difficulty quitting smoking.
Not a fit: Patients who do not use tobacco products or have no history of nicotine dependence may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic approaches for helping individuals quit smoking and manage withdrawal symptoms more effectively.
How similar studies have performed: Previous research has shown promising results in understanding the role of brain cells in addiction, suggesting that this approach could yield valuable insights.
Where this research is happening
Boulder, UNITED STATES
- University of Colorado — Boulder, United States (Active)
Researchers
- Principal investigator: Ehringer, Marissa a — University of Colorado
- Study coordinator: Ehringer, Marissa a
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.